Pharma & Biopharma

Super-resolution microscopy uncovers antibody mechanisms against cancer with molecular precision

Our 2024 Human Health Pioneers reveal the analytical frontiers in human health and disease they’re most excited about

How do people get involved in biopharma – and what keeps them there? Welcome to the first chapter of “So You Want to Be a Biopharmaceutical Analyst.”

The 2024 Power List tell us about important problems that could – and should – be tackled through interdisciplinary work

Study provides a framework for controlling molecular reactions at the atomic scale – with potential implications for nanotechnology and pharma

The countdown begins! We reveal the first five innovations to make this year’s Innovation Awards.

We asked The 2024 Power List: what’s missing from the analytical toolbox?

Stefan Foser, VP of Global Pharma at Bruker, reflects on the importance of analytical technology in the “post-genomic era”

Advancements in sample preparation, coupling separations, and data collection are paving the way for broader CD-MS adoption

Why Evan Williams is surprised that more companies aren’t interested in commercializing charge-detection technologies